|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03692 HANSOH PHARMA
Nominal 
18.520 +0.260 (+1.424%) Ranking Overview
Ranking based on 7 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
7
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 55.00 RMB (cts) | |
| Net Profit | 3,277.50 RMB (MIL) | DPS | 19.31 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 4,172.00 | 70.00 | 18.25 | -- | 4,368.00 | 3,661.00 |
| 2025 | 3,502.00 | 59.00 | 18.25 | -- | 4,030.00 | 3,251.00 |
| 2026 | 3,893.00 | 65.00 | 19.91 | -- | 4,089.00 | 3,652.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 3,946.00 | 66.40 | 13.92 | CITIGROUP | Buy | 28.50 | 11/09/2024 | |
| 2024 | 3,732.00 | 76.00 | -- | CHINA MERCHANTS | Buy | 26.50 | 28/08/2024 | |
| 2024 | 4,368.00 | 74.00 | -- | CMB INT'L SEC | Buy | 24.11 | 29/08/2024 | |
| 2024 | 4,294.00 | 72.40 | -- | BANK OF AMERICA | Buy | 23.90 | 13/11/2024 | |
| 2024 | 4,208.00 | 70.00 | 25.00 | UBS | Buy | 22.10 | 28/08/2024 | |
| 2024 | 4,172.00 | 70.00 | 24.00 | HSBC | Buy | 22.00 | 15/11/2024 | |
| 2024 | 3,661.00 | 62.00 | 18.25 | MORGAN STANLEY | Overweight | 22.00 | 27/08/2024 | |
| 2025 | 3,826.00 | 64.40 | 12.18 | CITIGROUP | -- | -- | 11/09/2024 | |
| 2025 | 4,030.00 | 83.00 | -- | CHINA MERCHANTS | -- | -- | 28/08/2024 | |
| 2025 | 3,271.00 | 55.00 | -- | CMB INT'L SEC | -- | -- | 29/08/2024 | |
| 2025 | 3,251.00 | 54.80 | -- | BANK OF AMERICA | -- | -- | 13/11/2024 | |
| 2025 | 3,543.00 | 59.00 | 21.00 | UBS | -- | -- | 28/08/2024 | |
| 2025 | 3,371.00 | 57.00 | 19.00 | HSBC | -- | -- | 15/11/2024 | |
| 2025 | 3,502.00 | 59.00 | 18.25 | MORGAN STANLEY | -- | -- | 27/08/2024 | |
| 2026 | 4,020.00 | 67.60 | 13.92 | CITIGROUP | -- | -- | 11/09/2024 | |
| 2026 | 3,652.00 | 62.00 | -- | CMB INT'L SEC | -- | -- | 29/08/2024 | |
| 2026 | 3,683.00 | 62.10 | -- | BANK OF AMERICA | -- | -- | 13/11/2024 | |
| 2026 | 4,032.00 | 67.00 | 24.00 | UBS | -- | -- | 28/08/2024 | |
| 2026 | 4,089.00 | 69.00 | 19.91 | MORGAN STANLEY | -- | -- | 27/08/2024 | |
| 2026 | 3,766.00 | 63.00 | 22.00 | HSBC | -- | -- | 15/11/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 22/11/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,725,525 |
| %Change | 111.470% |
| EPS / (LPS) | RMB 0.460 |
| NBV Per Share (¥) | RMB 4.701 |